Principal Financial Group Inc. raised its position in Envista Holdings Corporation (NYSE:NVST – Free Report) by 36.8% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 483,983 shares of the company’s stock after purchasing an additional 130,237 shares during the period. Principal Financial Group Inc.’s holdings in Envista were worth $12,279,000 as of its most recent SEC filing.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Royal Bank of Canada raised its stake in shares of Envista by 26.6% during the 1st quarter. Royal Bank of Canada now owns 23,240 shares of the company’s stock worth $401,000 after purchasing an additional 4,885 shares during the period. Millennium Management LLC grew its stake in shares of Envista by 218.6% during the 1st quarter. Millennium Management LLC now owns 383,966 shares of the company’s stock worth $6,627,000 after acquiring an additional 263,442 shares during the period. Goldman Sachs Group Inc. increased its stake in shares of Envista by 39.3% in the first quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company’s stock worth $10,859,000 after purchasing an additional 177,630 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Envista by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company’s stock valued at $9,821,000 after buying an additional 76,246 shares in the last quarter. Finally, Prudential Financial Inc. grew its holdings in Envista by 22.1% during the 2nd quarter. Prudential Financial Inc. now owns 18,785 shares of the company’s stock valued at $367,000 after buying an additional 3,395 shares in the last quarter.
Envista Stock Performance
Shares of Envista stock opened at $26.34 on Friday. The firm’s 50-day moving average is $25.19 and its 200 day moving average is $25.74. Envista Holdings Corporation has a 1 year low of $18.77 and a 1 year high of $30.42. The company has a debt-to-equity ratio of 0.47, a current ratio of 2.44 and a quick ratio of 2.06. The stock has a market cap of $4.29 billion, a price-to-earnings ratio of 64.26, a PEG ratio of 1.48 and a beta of 0.86.
Analyst Upgrades and Downgrades
NVST has been the subject of several research analyst reports. Robert W. Baird lifted their price objective on Envista from $30.00 to $31.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Weiss Ratings cut shares of Envista from a “hold (c)” rating to a “hold (c-)” rating in a research report on Monday, May 11th. Barclays decreased their price objective on Envista from $34.00 to $32.00 and set an “overweight” rating on the stock in a report on Thursday, June 11th. Zacks Research cut shares of Envista from a “strong-buy” rating to a “hold” rating in a research report on Monday, April 6th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Envista from $26.00 to $29.00 and gave the company a “neutral” rating in a research note on Thursday, May 7th. Six analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $28.54.
Check Out Our Latest Stock Analysis on Envista
About Envista
Envista Holdings Corporation is a global dental products company that develops, manufactures and markets a broad portfolio of dental consumables, equipment and technology solutions. Headquartered in Brea, California, Envista serves dental practitioners, specialists and laboratories in more than 150 countries. The company’s offerings span implant, orthodontic, endodontic and restorative product lines as well as digital imaging systems and practice management software.
Envista’s product brands include Nobel Biocare for dental implants and restorative solutions, Ormco for orthodontic appliances and treatment systems, Kerr for restorative and endodontic materials, KaVo for dental imaging and handpieces, and Vista for surgical drills and instruments.
Further Reading
- Five stocks we like better than Envista
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding NVST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Envista Holdings Corporation (NYSE:NVST – Free Report).
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.
